首页 | 本学科首页   官方微博 | 高级检索  
检索        

增强BEACOPP方案治疗晚期霍奇金淋巴瘤患者的远期疗效及安全性
引用本文:李文瑜[评价者],黄玲[文献合成者].增强BEACOPP方案治疗晚期霍奇金淋巴瘤患者的远期疗效及安全性[J].循证医学,2014,14(2):74-76.
作者姓名:李文瑜[评价者]  黄玲[文献合成者]
作者单位:广东省人民医院肿瘤中心、广东省医学科学院, 广州510080
摘    要:1文献来源 Engert A, Diehl V, Escalated-dose BEACOPP patients with advanced-stage Franklin J, et al. in the treatment of Hodgkin' s lymphoma :10 years of follow-up of the GHSG HD9 study J]. J Clin Oncol, 2009, 27(27) : 4548-4554.

关 键 词:晚期霍奇金淋巴瘤  增强  BEACOPP方案  无治疗失败生存率  总生存率

Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients
LI Wen-yu,HUANG Ling.Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients[J].The Journal of Evidence-Based Medicine,2014,14(2):74-76.
Authors:LI Wen-yu  HUANG Ling
Institution:Authors’ address: Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
Abstract:advanced stage Hodgkin lymphoma BEACOPP escalated-dose regimen freedom from treatment failure overall survival
Keywords:advanced stage Hodgkin lymphoma  BEACOPP escalated-dose regimen  freedom from treatment failure  overall survival
本文献已被 维普 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号